TWC
GMAB icon

TD Waterhouse Canada’s Genmab GMAB Stock Holding History

TD Waterhouse Canada’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33
Closed -$820 – 1965
2024
Q2 		$820 Buy
+33
New +$936 ﹤0.01% 1735
2024
Q1 		– Sell
-7,169
Closed -$232K – 1832
2023
Q4 		$232K Sell
7,169
-1,335
-16% -$41.9K ﹤0.01% 653
2023
Q3 		$297K Buy
8,504
+89
+1% +$3.39K ﹤0.01% 584
2023
Q2 		$326K Buy
8,415
+6,449
+328% +$257K ﹤0.01% 597
2023
Q1 		$74.9K Buy
1,966
+1,486
+310% +$57.1K ﹤0.01% 828
2022
Q4 		$22K Buy
480
+232
+94% +$9.56K ﹤0.01% 1077
2022
Q3 		$9.93K Hold
248
– – ﹤0.01% 1233
2022
Q2 		$9.5K Buy
248
+30
+14% +$972 ﹤0.01% 1260
2022
Q1 		$8.88K Sell
218
-59,500
-100% -$2.04M ﹤0.01% 1356
2021
Q4 		$2.31M Buy
+59,718
New +$2.49M 0.02% 346

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TD Waterhouse Canada's GMAB Position: Q3 2024 in Review

TD Waterhouse Canada sold out of Genmab (GMAB) in Q3 2024, closing a stake of 33 shares — an estimated $820 sold.

TD Waterhouse Canada first reported a position in GMAB in Q4 2021 and held it in 10 quarters. The position peaked at $2.31M in Q4 2021. 223 funds tracked by Wall St. Rank hold GMAB as of Q3 2024.

  • TD Waterhouse Canada reported no remaining Genmab position as of Q3 2024 after selling out during the quarter.
  • TD Waterhouse Canada sold 33 Genmab shares in Q3 2024, an estimated $820.
  • TD Waterhouse Canada first reported a position in Genmab in Q4 2021 and held it in 10 quarters.
  • TD Waterhouse Canada's Genmab position peaked at $2.31M in Q4 2021.
  • 223 funds tracked by Wall St. Rank held Genmab as of Q3 2024.

Based on TD Waterhouse Canada's 13F filing for Q3 2024, filed 12 Nov 2024.